COVID-19 vaccination in the UK: Addressing vaccine hesitancy
With the success of COVID-19 vaccine trials and its official rollout in the UK, the attention has
turned towards vaccine distribution and its uptake. Vaccine hesitancy, one of the top ten …
turned towards vaccine distribution and its uptake. Vaccine hesitancy, one of the top ten …
COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room
P Olliaro, E Torreele, M Vaillant - The Lancet Microbe, 2021 - thelancet.com
Approximately 96 COVID-19 vaccines are at various stages of clinical development. 1 At
present, we have the interim results of four studies published in scientific journals (on the …
present, we have the interim results of four studies published in scientific journals (on the …
Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination
RM Anderson, C Vegvari, J Truscott, BS Collyer - The Lancet, 2020 - thelancet.com
Comment www. thelancet. com Vol 396 November 21, 2020 1615 post licensure of a COVID-
19 vaccine. As such, the impact of vaccination on the transmission of SARS-CoV-2 will start …
19 vaccine. As such, the impact of vaccination on the transmission of SARS-CoV-2 will start …
[HTML][HTML] Uncoupling of all-cause excess mortality from COVID-19 cases in a highly vaccinated state
Uncoupling of all-cause excess mortality from COVID-19 cases in a highly vaccinated state -
The Lancet Infectious Diseases Skip to Main Content Advertisement The Lancet Infectious …
The Lancet Infectious Diseases Skip to Main Content Advertisement The Lancet Infectious …
Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a …
EJ Haas, JM McLaughlin, F Khan, FJ Angulo… - The Lancet Infectious …, 2022 - thelancet.com
Summary Background On Dec 20, 2020, Israel initiated a nationwide COVID-19 vaccination
campaign for people aged 16 years and older and exclusively used the Pfizer–BioNTech …
campaign for people aged 16 years and older and exclusively used the Pfizer–BioNTech …
Are bivalent vaccines better than ancestral-virus monovalent vaccines in protecting against severe omicron COVID-19?
SA Madhi, DR Feikin - The Lancet Infectious Diseases, 2023 - thelancet.com
In The Lancet Infectious Diseases, Alberto Mateo-Urdiales and colleagues used a quasi-
experimental study design to evaluate relative vaccine effectiveness (rVE) of a second …
experimental study design to evaluate relative vaccine effectiveness (rVE) of a second …
What is the vaccine effect on reducing transmission in the context of the SARS-CoV-2 delta variant?
A Wilder-Smith - The Lancet Infectious Diseases, 2022 - thelancet.com
COVID-19 vaccines that have obtained WHO emergency use listing appear to have high
efficacy against severe disease and death, but lower efficacy against nonsevere infections …
efficacy against severe disease and death, but lower efficacy against nonsevere infections …
The big catch-up in immunisation coverage after the COVID-19 pandemic: Progress and challenges to achieving equitable recovery
KL O'Brien, E Lemango - The Lancet, 2023 - thelancet.com
Each year in mid-July WHO and UNICEF jointly release Estimates of National Immunization
Coverage (WUENIC) for 195 member states. These estimates are the culmination of a …
Coverage (WUENIC) for 195 member states. These estimates are the culmination of a …
Delayed COVID-19 vaccine roll-out in Japan
M Kosaka, T Hashimoto, A Ozaki, T Tanimoto, M Kami - The Lancet, 2021 - thelancet.com
Evidence is weak on global policies and guidelines regarding quarantine and testing
measures for vaccinated health-care workers (HCWs) who might have been exposed to …
measures for vaccinated health-care workers (HCWs) who might have been exposed to …